Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1960 Jan 9;1(5166):73–78. doi: 10.1136/bmj.1.5166.73

Bleeding after Perfusion for Open Heart Surgery

N G Rothnie, J B Kinmonth
PMCID: PMC1966151  PMID: 14439470

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN I. W., Jr, SMITH W. W. Hematologic problems associated with the use of extracorporeal circulation for cardiovascular surgery. Ann Intern Med. 1958 Nov;49(5):1035–1048. doi: 10.7326/0003-4819-49-5-1035. [DOI] [PubMed] [Google Scholar]
  2. BURSTEIN M., GUINAND A. Sur la spécificité du fibrinogène des mammifères. I. Temps de thrombine du plasma de quelques mammifères; rôle du pH et du calcium. Rev Hematol. 1954;9(2):231–242. [PubMed] [Google Scholar]
  3. CRADDOCK C. G., Jr, ADAMS W. S., PERRY S., LAWRENCE J. S. The dynamics of platelet production as studied by a depletion technique in normal and irradiated dogs. J Lab Clin Med. 1955 Jun;45(6):906–919. [PubMed] [Google Scholar]
  4. EIBER H. B., DANISHEFSKY I. Synthesis and metabolism of radioactive heparin. AMA Arch Intern Med. 1958 Aug;102(2):189–193. doi: 10.1001/archinte.1958.00260200017003. [DOI] [PubMed] [Google Scholar]
  5. FORWELL G. D., INGRAM G. I. The anticoagulant activity of dextran sulphate. I. An in vitro comparison between the actions of dextran sulphate and heparin on the various stages of blood coagulation. J Pharm Pharmacol. 1956 Jul;8(7):530–545. [PubMed] [Google Scholar]
  6. GERBODE F., HURT R., MACKENZIE R., OSBORN J. J., PERKINS H., SHAW A. Cause and prevention of hemorrhage following extracorporeal circulation. Surg Forum. 1956;6:96–100. [PubMed] [Google Scholar]
  7. GERBODE F., HURT R., OSBORN J. J., PERKINS H. A. The neutralization of heparin by protamine in extracorporeal circulation. J Thorac Surg. 1956 Nov;32(5):612–619. [PubMed] [Google Scholar]
  8. GOLLUB S., ULIN A. W., WINCHELL H. S., EHRLICH E., WEISS W. Hemorrhagic diathesis associated with massive transfusion. Surgery. 1959 Feb;45(2):204–222. [PubMed] [Google Scholar]
  9. INGRAM G. I. C., ARMITAGE P. The effect of penicillin and of streptomycin on blood coagulation in normal subjects. J Pharm Pharmacol. 1952 Dec;4(12):1047–1061. doi: 10.1111/j.2042-7158.1952.tb13239.x. [DOI] [PubMed] [Google Scholar]
  10. INGRAM G. I. Variations in the reaction between thrombin and fibrinogen and their effect on the prothrombin time. J Clin Pathol. 1955 Nov;8(4):318–323. doi: 10.1136/jcp.8.4.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. PERKINS H. A., OSBORN J. J., HURT R., GERBODE F. Neutralization of heparin in vivo with protamine; a simple method of estimating the required dose. J Lab Clin Med. 1956 Aug;48(2):223–226. [PubMed] [Google Scholar]
  12. STEFANINI M. Seminars on blood coagulation; mechanism of blood coagulation in normal and pathologic conditions. Am J Med. 1953 Jan;14(1):64–86. doi: 10.1016/0002-9343(53)90359-3. [DOI] [PubMed] [Google Scholar]
  13. VAN CREVELD S. Functional pathology of the platelets. Acta Haematol. 1954 Oct;12(4):229–237. doi: 10.1159/000204624. [DOI] [PubMed] [Google Scholar]
  14. VON KAULLA K. N., SWAN H. Clotting deviations in man during cardiac bypass: fibrinolysis and circulating anticoagulant. J Thorac Surg. 1958 Oct;36(4):519–530. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES